ArticleCancer science2009

Association of TP53 and MDM2 polymorphisms with survival in bladder cancer patients treated with chemoradiotherapy.

Asano Shinohara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.